EP 2641968 A4 20140416 - ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND -D-GALACTOSIDASE
Title (en)
ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND -D-GALACTOSIDASE
Title (de)
ORAL VERABREICHBARE PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR PRÄVENTION UND BEHANDLUNG DES REIZDARMSYNDROMS MIT EINEM MODIFIKATOR DER INTESTINALEN BEWEGLICHKEIT UND ALPHA-D-GALACTOSIDASE SOWIE VERFAHREN ZU IHRER HERSTELLUNG
Title (fr)
COMPOSITION PHARMACEUTIQUE ADAPTÉE À L'ADMINISTRATION PAR VOIE ORALE ET SON PROCÉDÉ DE PRÉPARATION AVEC UN MODIFICATEUR DE LA MOTILITÉ INTESTINALE ET UNE -D-GALAGTOSIDASE, UTILISATION DE LADITE COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION ET LE TRAITEMENT DU SYNDROME DE L'INTESTIN IRRITABLE
Publication
Application
Priority
- MX 2010012480 A 20101116
- MX 2011000139 W 20111115
Abstract (en)
[origin: EP2641968A2] The invention relates to a pharmaceutical formulation or composition in the form of a tablet, coated tablet, capsule or powder for reconstitution, for use in irritable bowel syndrome, comprising an intestinal motility modifier and enzyme ±-D-galactosidase.
IPC 8 full level
A61K 31/14 (2006.01); A61K 31/05 (2006.01); A61K 31/4045 (2006.01); A61K 31/437 (2006.01); A61K 31/451 (2006.01); A61K 31/46 (2006.01); A61K 31/5415 (2006.01); A61K 38/43 (2006.01); A61K 45/06 (2006.01); A61P 1/00 (2006.01); C12N 9/40 (2006.01)
CPC (source: EP KR US)
A61K 9/14 (2013.01 - KR); A61K 9/20 (2013.01 - KR); A61K 9/2018 (2013.01 - EP US); A61K 9/2054 (2013.01 - EP US); A61K 9/2059 (2013.01 - EP US); A61K 9/2077 (2013.01 - EP US); A61K 9/28 (2013.01 - KR); A61K 9/48 (2013.01 - KR); A61K 31/05 (2013.01 - EP US); A61K 31/14 (2013.01 - EP US); A61K 31/215 (2013.01 - EP US); A61K 31/216 (2013.01 - EP US); A61K 31/24 (2013.01 - EP US); A61K 31/404 (2013.01 - EP US); A61K 31/4045 (2013.01 - EP US); A61K 31/437 (2013.01 - EP US); A61K 31/439 (2013.01 - EP US); A61K 31/451 (2013.01 - EP US); A61K 31/46 (2013.01 - EP US); A61K 31/5375 (2013.01 - EP US); A61K 31/541 (2013.01 - EP US); A61K 31/5415 (2013.01 - EP US); A61K 38/43 (2013.01 - KR); A61K 38/47 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61K 47/02 (2013.01 - US); A61K 47/12 (2013.01 - US); A61K 47/26 (2013.01 - US); A61K 47/38 (2013.01 - US); A61P 1/00 (2017.12 - EP); A61P 1/06 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/18 (2017.12 - EP)
Citation (search report)
- [XI] US 2008038336 A1 20080214 - ESQUEA MARTA LUZ TORRES [CO], et al
- [X] US 2004009234 A1 20040115 - MEISEL GERARD M [US], et al
- [XI] WO 9501803 A1 19950119 - MERCK & CO INC [US], et al
- [I] HASLER ET AL: "Irritable bowel syndrome and bloating", BAILLIERE'S BEST PRACTICE AND RESEARCH. CLINICAL GASTROENTEROLOGY, BAILLIERE TINDALL, LONDON, US, vol. 21, no. 4, 1 August 2007 (2007-08-01), pages 689 - 707, XP022204251, ISSN: 1521-6918, DOI: 10.1016/J.BPG.2007.03.007
- See references of WO 2012067482A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 2641968 A2 20130925; EP 2641968 A4 20140416; AR 083889 A1 20130327; AU 2011329917 A1 20130606; BR 112013012102 A2 20160816; CA 2818130 A1 20120524; CL 2013001332 A1 20140523; CN 103392000 A 20131113; CO 6811847 A2 20131216; CR 20130220 A 20130920; DO P2013000109 A 20131115; EC SP13012643 A 20131031; JP 2013542986 A 20131128; KR 20140037798 A 20140327; MA 34730 B1 20131203; MX 2010012480 A 20120516; PE 20140379 A1 20140323; RU 2013127273 A 20141227; US 2015150953 A1 20150604; UY 33732 A 20120629; WO 2012067482 A2 20120524; WO 2012067482 A3 20120719; ZA 201304157 B 20160127
DOCDB simple family (application)
EP 11841178 A 20111115; AR P110104273 A 20111116; AU 2011329917 A 20111115; BR 112013012102 A 20111115; CA 2818130 A 20111115; CL 2013001332 A 20130514; CN 201180065136 A 20111115; CO 13143132 A 20130614; CR 20130220 A 20130514; DO 2013000109 A 20130516; EC SP13012643 A 20130527; JP 2013539789 A 20111115; KR 20137015555 A 20111115; MA 36003 A 20130610; MX 2010012480 A 20101116; MX 2011000139 W 20111115; PE 2013001061 A 20111115; RU 2013127273 A 20111115; US 201113885629 A 20111115; UY 33732 A 20111114; ZA 201304157 A 20130606